Candel Therapeutics, Inc. (CADL)
NASDAQ: CADL · IEX Real-Time Price · USD
1.580
+0.040 (2.60%)
At close: Mar 28, 2024, 4:00 PM
1.710
+0.130 (8.23%)
After-hours: Mar 28, 2024, 6:51 PM EDT
Candel Therapeutics Market Cap
Candel Therapeutics has a market cap or net worth of $43.09 million as of March 28, 2024. Its market cap has increased by 5.87% in one year.
Market Cap
43.09M
Enterprise Value
22.61M
1-Year Change
5.87%
Ranking
Category
Stock Price
$1.58
Market Cap Chart
Since the IPO on July 27, 2021, Candel Therapeutics's market cap has decreased from $222.39M to $43.09M, a decrease of -80.62%. That is a compound annual growth rate of -45.94%.
Market Cap History
Date | Market Cap | % Change |
---|---|---|
Mar 27, 2024 | 44.50M | 3.25% |
Mar 26, 2024 | 43.10M | -2.05% |
Mar 25, 2024 | 44.00M | 1.38% |
Mar 22, 2024 | 43.40M | 3.58% |
Mar 21, 2024 | 41.90M | -3.46% |
Mar 20, 2024 | 43.40M | - |
Mar 19, 2024 | 43.40M | 7.16% |
Mar 18, 2024 | 40.50M | -6.68% |
Mar 15, 2024 | 43.40M | -3.77% |
Mar 14, 2024 | 45.10M | -0.66% |
Mar 13, 2024 | 45.40M | -2.58% |
Mar 12, 2024 | 46.60M | -4.12% |
Mar 11, 2024 | 48.60M | 7.05% |
Mar 8, 2024 | 45.40M | 2.71% |
Mar 7, 2024 | 44.20M | -3.28% |
Mar 6, 2024 | 45.70M | -2.97% |
Mar 5, 2024 | 47.10M | -1.26% |
Mar 4, 2024 | 47.70M | -3.05% |
Mar 1, 2024 | 49.20M | -8.55% |
Feb 29, 2024 | 53.80M | 3.86% |
Feb 28, 2024 | 51.80M | 2.98% |
Feb 27, 2024 | 50.30M | -2.33% |
Feb 26, 2024 | 51.50M | 1.78% |
Feb 23, 2024 | 50.60M | 1.00% |
Feb 22, 2024 | 50.10M | -1.57% |
View and export this data all the way back to 2021.
Sign Up Today.
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
Company | Market Cap |
---|---|
Apyx Medical | 44.34M |
DIH Holdings US | 44.19M |
Spectral AI | 44.16M |
eFFECTOR Therapeutics | 44.11M |
Prenetics Global | 43.45M |
Marker Therapeutics | 43.02M |
Estrella Immunopharma | 42.95M |
Tiziana Life Sciences | 42.73M |